N-oxides as hypoxia selective cytotoxins

Mini Rev Med Chem. 2001 Sep;1(3):219-31. doi: 10.2174/1389557013406891.

Abstract

N-oxide-containing compounds have been developed as prodrugs that are selectively bioactivated in the hypoxic cells in tumors. This selectivity is based on the net reduction of the N-oxide moiety in the absence of oxygen, in a one or two-electron process, by reductive enzymes. A wide range of N-oxides have been studied and some of them are currently in clinical use. This review covers the principal families of compounds under study and in clinical trials.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antioxidants / chemical synthesis
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Cell Hypoxia / drug effects*
  • Cytotoxins / chemical synthesis*
  • Cytotoxins / chemistry
  • Cytotoxins / pharmacology
  • Drug Design
  • Humans
  • Models, Molecular
  • Molecular Conformation
  • Neoplasms / pathology
  • Nitrogen Oxides / chemical synthesis*
  • Nitrogen Oxides / pharmacology
  • Structure-Activity Relationship

Substances

  • Antioxidants
  • Cytotoxins
  • Nitrogen Oxides